β2-adrenergic receptor genotype and pulmonary function in patients with heart failure

Chest

Volumn 130, Issue 5, 2006, Pages 1527-1534

  Snyder, Eric M ^a   Turner, Stephen T ^a   Johnson, Bruce D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Airway; Congestive heart failure; Echocardiography; Receptors

Indexed keywords

ADRENALIN; ARGININE; BETA 2 ADRENERGIC RECEPTOR; GLYCINE; NORADRENALIN; DNA;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOMOZYGOSITY; HUMAN; LUNG CLEARANCE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SMOOTH MUSCLE TONE; BLOOD PRESSURE; CASE CONTROL STUDY; FORWARD HEART FAILURE; GENETICS; HOMOZYGOTE; LUNG; LUNG DISEASE; LUNG VOLUME; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARGININE; BLOOD PRESSURE; CARDIAC OUTPUT, LOW; CASE-CONTROL STUDIES; DNA; FEMALE; GLYCINE; HOMOZYGOTE; HUMANS; LUNG; LUNG DISEASES; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DIFFUSING CAPACITY; RECEPTORS, ADRENERGIC, BETA-2;

EID: 33749822380     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.5.1527     Document Type: Article

References (47)

1. Collins JV, Clark TJ, Brown DJ. Airway function in healthy subjects and patients with left heart disease. Clin Sci Mol Med 1975; 49:217-228
2. Johnson BD, Beck KC, Olson LJ, et al. Ventilatory constraints during exercise in patients with chronic heart failure. Chest 2000; 117:321-332
3. Guazzi M, Marenzi G, Alimento M, et al. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997; 95:1930-1936
4. Gehlbach BK, Geppert E. The pulmonary manifestations of left heart failure. Chest 2004; 125:669-682
5. Al-Rawas OA, Carter R, Stevenson RD, et al. The alveolar-capillary membrane diffusing capacity and the pulmonary capillary blood volume in heart transplant candidates. Heart 2000; 83:156-160
6. Ng TM, Munger MA, Lombardi WL, et al. Chronically inhaled salmeterol improves pulmonary function in heart failure. J Cardiovasc Pharmacol 2002; 40:140-145
7. Carstairs JR, Nimmo AJ, Barnes PJ. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis 1985; 132:541-547
8. 2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography. Eur J Pharmacol 1991; 206:133-138
9. Giembycz MA, Raeburn D. Putative substrates for cyclic nucleotide-dependent protein kinases and the control of airway smooth muscle tone. J Auton Pharmacol 1991; 11:365-398
10. Matalon S, Lazrak A, Jain L, et al. Invited review: biophysical properties of sodium channels in lung alveolar epithelial cells. J Appl Physiol 2002; 93:1852-1859
11. Eaton DC, Chen J, Ramosevac S, et al. Regulation of Na+ channels in lung alveolar type II epithelial cells. Proc Am Thorac Soc 2004; 1:10-16
12. Mahe L, Chapelain B, Gargouil YM, et al. Characterization of β-adrenoceptor subtypes and indications for two cell populations in isolated bovine mesenteric lymphatic vessels. Eur J Pharmacol 1991; 199:19-25
13. Lauweryns JM, Baert JH. Alveolar clearance and the role of the pulmonary lymphatics. Am Rev Respir Dis 1977; 115:625-683
14. 2- adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 1998; 102:1534-1539
15. 2-adrenoceptor Thr164Ile polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo. Pharmacogenetics 2004; 14:517-522
16. 2- adrenergic receptor genotype on airway function during exercise in healthy adults. Chest 2006; 129:762-770
17. 2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans. J Physiol 2006; 571:121-130
18. 2-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 2000; 36:371-375
19. 2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001; 345:1030-1035
20. 2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise. Physiol Genomics 2004; 16:323-328
21. 2-adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol 2003; 546:583-589
22. Kaye DM, Lefkovits J, Jennings GL, et al. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995; 26:1257-1263
23. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311:819-823
24. 2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000; 101:2877-2882
25. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367
26. Oh JK, Appleton CP, Hatle LK, et al. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997; 10:246-270
27. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
28. 2-adrenergic receptors in airway epithelial cells decreases bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 2000; 279:L379-L389
29. 2-agonists regulate cell surface expression of the epithelial sodium channel in native alveolar epithelial cells. J Biol Chem 2002; 277:47318-47324
30. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000; 97:10483-10488
31. 2-adrenergic receptor and left ventricular systolic function. Am J Hypertens 2003; 16:945-951
32. Pavia D, Bateman JR, Lennard-Jones AM, et al. Effect of selective and non-selective β blockade on pulmonary function and tracheobronchial mucociliary clearance in healthy subjects. Thorax 1986; 41:301-305
33. Bussieres LM, Pflugfelder PW, Ahmad D, et al. Evolution of resting lung function in the first year after cardiac transplantation. Eur Respir J 1995; 8:959-962
34. Agostoni P, Cattadori G, Bianchi M, et al. Exercise-induced pulmonary edema in heart failure. Circulation 2003; 108:2666-2671
35. Chua TP, Coats AJ. The lungs in chronic heart failure. Eur Heart J 1995; 16:882-887
36. Ohar J, Osterloh J, Ahmed N, et al. Diffusing capacity decreases after heart transplantation. Chest 1993; 103:857-861
37. Ravenscraft SA, Gross CR, Kubo SH, et al. Pulmonary function after successful heart transplantation: one year follow-up. Chest 1993; 103:54-58
38. 2-adrenergic receptor gene affects cardiovascular function, in heart failure. Physiologist 2002; 45:1
39. 2-adrenergic receptors during halothane anesthesia. Anesthesiology 1995; 82:1417-1425
40. 2-adrenergic receptors. Life Sci 1995; 57:PL327-PL332
41. Schneider DA, Kamimori GH, Wu SY, et al. Plasma catecholamine and ventilatory responses to cycling after propranolol treatment. Med Sci Sports Exerc 1995; 27:1616-1620
42. Rahn KH, Gierlichs HW, Planz G, et al. Studies on the effects of propanolol on plasma catecholamine levels in patients with essential hypertension. Eur J Clin Invest 1978; 8:143-148
43. Galbo H, Holst JJ, Christensen NJ, et al. Glucagon and plasma catecholamines during β-receptor blockade in exercising man. J Appl Physiol 1976; 40:855-863
44. Axelrod J, Weinshilboum R. Catecholamines. N Engl J Med 1972; 287:237-242
45. Halter JB, Pflug AE, Tolas AG. Arterial-venous differences of plasma catecholamines in man. Metabolism 1980; 29:9-12
46. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127:725-734
47. Miller A, Thornton JC. Reference equations for the single-breath diffusing capacity. Am Rev Respir Dis 1986; 133:1210-1211